Compounds > debrisoquin

debrisoquin and mexiletine

debrisoquin has been researched along with mexiletine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Broly, F; Lhermitte, M; Libersa, C; Vandamme, N1
Broly, F; Caron, J; Lhermitte, M; Libersa, C; Vandamme, N1
Abrams, SM; Johnston, A; Lledó, P; Patel, M; Pearson, RM; Turner, P1

Other Studies

5 other study(ies) available for debrisoquin and mexiletine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation.
    British journal of clinical pharmacology, 1991, Volume: 32, Issue:4

    Topics: Adult; Debrisoquin; Female; Humans; Hydroxylation; Male; Mexiletine; Phenotype; Polymorphism, Genetic; Smoking; Sparteine

1991
Single-dose quinidine treatment inhibits mexiletine oxidation in extensive metabolizers of debrisoquine.
    Life sciences, 1991, Volume: 48, Issue:26

    Topics: Debrisoquin; Drug Antagonism; Humans; Metabolic Clearance Rate; Mexiletine; Oxidation-Reduction; Quinidine

1991
Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine.
    European journal of clinical pharmacology, 1993, Volume: 44, Issue:1

    Topics: Adult; Debrisoquin; Female; Humans; Hydrogen-Ion Concentration; Hydroxylation; Infusions, Intravenous; Liver; Male; Mexiletine; Phenotype

1993